NewGenIvf面临来自Nasdaq的除名,但试图上诉并搬到Nasdaq资本市场。 NewGenIvf faces delisting from Nasdaq but seeks to appeal and move to Nasdaq Capital Market.

NewGenIvf集团有限公司收到Nasdaq的除名通知,因为未达到公开持有股份的最低市场价值要求。 NewGenIvf Group Limited has received a delisting notice from Nasdaq due to failing to meet the minimum market value requirements for publicly held shares. 该公司已提出上诉,并计划将其证券转移到Nasdaq资本市场。 The company has filed an appeal and plans to move its securities to the Nasdaq Capital Market. NewGenIvf从两个投资者那里获得了高达1.2948亿美元的资金,以帮助解决其缺陷和继续开展业务。 NewGenIvf secured funding of up to $129.48 million from two investors to help address its deficiencies and continue operations.